Eribulin Use for the Treatment of Advanced Breast Cancer: A Prospective Observational Registry
Clinical trial NCT02443428 · COMPLETED
Trial details
- NCT number
- NCT02443428
- Sponsor
- Eisai Limited
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-08-01
- Primary completion
- 2015-10-01
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.